| Literature DB >> 35523848 |
Rachel Phelan1,2, Annie Im3, Hélène Schoemans4,5, André Tichelli6, Rebecca L Hunter7, Yoshihiro Inamoto8, Maria Teresa Lupo-Stanghellini9, Alicia Rovo10, Sherif M Badawy11,12, Linda Burns13, Hesham Eissa14, Hemant S Murthy15, Pinki Prasad16, Akshay Sharma17, Elizabeth Suelzer18, Vaibhav Agrawal19, Mahmoud Aljurf20, Karen Baker21, Grzegorz W Basak22, David Buchbinder23, Zachariah DeFilipp24, Lana Desnica Grkovic25, Ajoy Dias26, Hermann Einsele27, Michael L Eisenberg28, Narendranath Epperla29, Nosha Farhadfar30, Arthur Flatau31, Robert Peter Gale32, Hildegard Greinix33, Betty K Hamilton34, Shahrukh Hashmi35,36, Peiman Hematti37, Kareem Jamani38, Dipnarine Maharaj39, John Murray40, Seema Naik41, Sunita Nathan42, Steven Pavletic43, Zinaida Peric44, Drazen Pulanic44, Richard Ross45, Andrea Salonia46,47, Isabel Sanchez-Ortega48, Bipin N Savani49, Tal Schechter50, Ami J Shah51, Stephanie M Smith52, John A Snowden45,53, Amir Steinberg54, Douglas Tremblay55, Sarah C Vij56, Lauren Walker57, Daniel Wolff58, Jean A Yared59.
Abstract
Male-specific late effects after hematopoietic cell transplantation (HCT) include genital chronic graft-versus-host disease (GvHD), hypogonadism, sexual dysfunction, infertility, and subsequent malignancies. They may be closely intertwined and cause prolonged morbidity and decreased quality of life after HCT. We provide a systematic review of male-specific late effects in a collaboration between transplant physicians, endocrinologists, urologists, dermatologists, and sexual health professionals through the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research, and the Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. The systematic review summarizes incidence, risk factors, screening, prevention and treatment of these complications and provides consensus evidence-based recommendations for clinical practice and future research.Entities:
Mesh:
Year: 2022 PMID: 35523848 DOI: 10.1038/s41409-022-01591-z
Source DB: PubMed Journal: Bone Marrow Transplant ISSN: 0268-3369 Impact factor: 5.174